Top Strike Resources Corp. (VENI.CN)
CAD 0.02
(0.0%)
CAD 0.02
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -784.8 Thousand CAD | -59.93% |
| 2022 | -490.73 Thousand CAD | -40.1% |
| 2021 | -350.27 Thousand CAD | -20.82% |
| 2020 | -289.92 Thousand CAD | 85.12% |
| 2019 | -1.94 Million CAD | 8.78% |
| 2018 | -2.13 Million CAD | -10165.47% |
| 2017 | -20.81 Thousand CAD | 71.63% |
| 2016 | -73.36 Thousand CAD | -239.0% |
| 2015 | -21.64 Thousand CAD | 4.55% |
| 2014 | -22.67 Thousand CAD | 77.95% |
| 2013 | -102.8 Thousand CAD | -19.74% |
| 2012 | -85.85 Thousand CAD | -6.09% |
| 2011 | -80.92 Thousand CAD | 45.4% |
| 2010 | -148.22 Thousand CAD | 3.23% |
| 2009 | -153.16 Thousand CAD | 16.39% |
| 2008 | -183.19 Thousand CAD | 41.26% |
| 2007 | -311.87 Thousand CAD | 51.47% |
| 2006 | -642.6 Thousand CAD | 5.85% |
| 2005 | -682.52 Thousand CAD | 77.42% |
| 2004 | -3.02 Million CAD | -149.2% |
| 2003 | -1.21 Million CAD | -122.62% |
| 2002 | -544.92 Thousand CAD | 42.74% |
| 2001 | -951.7 Thousand CAD | 20.69% |
| 2000 | -1.19 Million CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q3 | -206.95 Thousand CAD | -258.52% |
| 2023 FY | -784.8 Thousand CAD | -59.93% |
| 2023 Q2 | -57.72 Thousand CAD | -162.82% |
| 2023 Q1 | -21.96 Thousand CAD | 72.14% |
| 2022 Q2 | -205.24 Thousand CAD | -49.56% |
| 2022 Q3 | -69.42 Thousand CAD | 66.18% |
| 2022 Q4 | -78.83 Thousand CAD | -13.56% |
| 2022 Q1 | -137.23 Thousand CAD | 83.25% |
| 2022 FY | -490.73 Thousand CAD | -40.1% |
| 2021 Q2 | 60.53 Thousand CAD | -73.49% |
| 2021 Q4 | -819.44 Thousand CAD | -368.61% |
| 2021 Q1 | 228.31 Thousand CAD | 168.44% |
| 2021 Q3 | -174.86 Thousand CAD | -388.9% |
| 2021 FY | -350.27 Thousand CAD | -20.82% |
| 2020 Q3 | -397.26 Thousand CAD | -526.33% |
| 2020 Q4 | -333.59 Thousand CAD | 16.03% |
| 2020 Q1 | -29.07 Thousand CAD | 87.43% |
| 2020 Q2 | -63.42 Thousand CAD | -118.14% |
| 2020 FY | -289.92 Thousand CAD | 85.12% |
| 2019 Q1 | -190.37 Thousand CAD | 86.3% |
| 2019 Q2 | -45.79 Thousand CAD | 75.94% |
| 2019 Q3 | 59.74 Thousand CAD | 230.47% |
| 2019 Q4 | -231.31 Thousand CAD | -487.15% |
| 2019 FY | -1.94 Million CAD | 8.78% |
| 2018 Q2 | -285.85 Thousand CAD | -8287.79% |
| 2018 Q4 | -1.38 Million CAD | -494.57% |
| 2018 FY | -2.13 Million CAD | -10165.47% |
| 2018 Q1 | -3408.00 CAD | 67.88% |
| 2018 Q3 | -233.67 Thousand CAD | 18.25% |
| 2017 Q3 | -3237.00 CAD | -12.91% |
| 2017 FY | -20.81 Thousand CAD | 71.63% |
| 2017 Q1 | -4094.00 CAD | 74.23% |
| 2017 Q2 | -2867.00 CAD | 29.97% |
| 2017 Q4 | -10.6 Thousand CAD | -227.74% |
| 2016 Q1 | -4102.00 CAD | 61.66% |
| 2016 FY | -73.36 Thousand CAD | -239.0% |
| 2016 Q2 | -40.19 Thousand CAD | -879.94% |
| 2016 Q3 | -13.16 Thousand CAD | 67.24% |
| 2016 Q4 | -15.88 Thousand CAD | -20.67% |
| 2015 Q1 | -5245.00 CAD | 52.13% |
| 2015 Q4 | -10.69 Thousand CAD | -374.41% |
| 2015 FY | -21.64 Thousand CAD | 4.55% |
| 2015 Q2 | -3446.00 CAD | 34.3% |
| 2015 Q3 | -2255.00 CAD | 34.56% |
| 2014 Q2 | -4500.00 CAD | -8.83% |
| 2014 Q1 | -4135.00 CAD | 88.47% |
| 2014 FY | -22.67 Thousand CAD | 77.95% |
| 2014 Q3 | -3080.00 CAD | 31.56% |
| 2014 Q4 | -10.95 Thousand CAD | -255.71% |
| 2013 Q4 | -35.86 Thousand CAD | -79.33% |
| 2013 Q3 | -19.99 Thousand CAD | 4.04% |
| 2013 Q2 | -20.84 Thousand CAD | 20.17% |
| 2013 Q1 | -26.1 Thousand CAD | -5.35% |
| 2013 FY | -102.8 Thousand CAD | -19.74% |
| 2012 Q3 | -28.67 Thousand CAD | -0.86% |
| 2012 Q4 | -24.78 Thousand CAD | 13.58% |
| 2012 Q1 | -3972.00 CAD | 86.86% |
| 2012 FY | -85.85 Thousand CAD | -6.09% |
| 2012 Q2 | -28.43 Thousand CAD | -615.79% |
| 2011 Q2 | -12.96 Thousand CAD | 46.36% |
| 2011 Q4 | -30.21 Thousand CAD | -122.82% |
| 2011 FY | -80.92 Thousand CAD | 45.4% |
| 2011 Q1 | -24.17 Thousand CAD | -153.16% |
| 2011 Q3 | -13.56 Thousand CAD | -4.57% |
| 2010 Q2 | -50.24 Thousand CAD | 30.72% |
| 2010 Q3 | -25.21 Thousand CAD | 49.81% |
| 2010 Q4 | -9550.00 CAD | 62.13% |
| 2010 FY | -148.22 Thousand CAD | 3.23% |
| 2010 Q1 | -72.52 Thousand CAD | -253.9% |
| 2009 Q4 | -20.49 Thousand CAD | 67.3% |
| 2009 FY | -153.16 Thousand CAD | 16.39% |
| 2009 Q1 | -34.75 Thousand CAD | -265.71% |
| 2009 Q3 | -62.67 Thousand CAD | -42.84% |
| 2009 Q2 | -43.87 Thousand CAD | -26.25% |
| 2008 Q4 | -9504.00 CAD | 88.23% |
| 2008 FY | -183.19 Thousand CAD | 41.26% |
| 2008 Q2 | -28.43 Thousand CAD | 58.02% |
| 2008 Q3 | -80.77 Thousand CAD | -184.12% |
| 2008 Q1 | -67.72 Thousand CAD | 2.76% |
| 2007 Q4 | -69.65 Thousand CAD | 10.66% |
| 2007 FY | -311.87 Thousand CAD | 51.47% |
| 2007 Q3 | -77.96 Thousand CAD | 0.0% |
| 2006 FY | -642.6 Thousand CAD | 5.85% |
| 2005 Q1 | -213.43 Thousand CAD | 91.81% |
| 2005 Q3 | -61.79 Thousand CAD | 51.74% |
| 2005 Q2 | -128.04 Thousand CAD | 40.01% |
| 2005 Q4 | -289.06 Thousand CAD | -367.79% |
| 2005 FY | -682.52 Thousand CAD | 77.42% |
| 2004 Q4 | -2.6 Million CAD | -2554.82% |
| 2004 FY | -3.02 Million CAD | -149.2% |
| 2004 Q3 | -98.14 Thousand CAD | 16.17% |
| 2004 Q2 | -117.08 Thousand CAD | 42.12% |
| 2004 Q1 | -202.29 Thousand CAD | 70.78% |
| 2003 Q2 | -190.45 Thousand CAD | -223.68% |
| 2003 FY | -1.21 Million CAD | -122.62% |
| 2003 Q4 | -692.32 Thousand CAD | -155.02% |
| 2003 Q3 | -271.48 Thousand CAD | -42.54% |
| 2003 Q1 | -58.84 Thousand CAD | 76.98% |
| 2002 Q4 | -255.59 Thousand CAD | -40.72% |
| 2002 Q1 | -41.97 Thousand CAD | 93.17% |
| 2002 Q2 | -65.72 Thousand CAD | -56.57% |
| 2002 Q3 | -181.63 Thousand CAD | -176.38% |
| 2002 FY | -544.92 Thousand CAD | 42.74% |
| 2001 Q2 | -66.81 Thousand CAD | 53.86% |
| 2001 Q1 | -144.8 Thousand CAD | 49.38% |
| 2001 FY | -951.7 Thousand CAD | 20.69% |
| 2001 Q3 | -125.12 Thousand CAD | -87.28% |
| 2001 Q4 | -614.97 Thousand CAD | -391.5% |
| 2000 Q1 | -274.88 Thousand CAD | 0.0% |
| 2000 FY | -1.19 Million CAD | 0.0% |
| 2000 Q4 | -286.05 Thousand CAD | 29.06% |
| 2000 Q3 | -403.22 Thousand CAD | -70.75% |
| 2000 Q2 | -236.14 Thousand CAD | 14.09% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -1.19 Million CAD | 34.103% |
| Ayurcann Holdings Corp. | -3.25 Million CAD | 75.859% |
| Blueberries Medical Corp. | -1.22 Million CAD | 36.017% |
| The BC Bud Corporation | -1.22 Million CAD | 35.855% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 87.675% |
| CordovaCann Corp. | -2.51 Million CAD | 68.765% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | 10.873% |
| Captor Capital Corp. | 655.2 Thousand CAD | 219.779% |
| City View Green Holdings Inc. | -996.45 Thousand CAD | 21.24% |
| 1CM Inc. | 300.79 Thousand CAD | 360.913% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | -42.25% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 79.768% |
| IM Cannabis Corp. | -12.17 Million CAD | 93.554% |
| Lobe Sciences Ltd. | -3.35 Million CAD | 76.639% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -100.094% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 75.367% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 244.725% |
| Ovation Science Inc. | -764 Thousand CAD | -2.722% |
| Pharmadrug Inc. | -1.33 Million CAD | 41.214% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | 31.277% |
| RAMM Pharma Corp. | -7.08 Million CAD | 88.925% |
| RIV Capital Inc. | 1.78 Million CAD | 144.084% |
| Revive Therapeutics Ltd. | -3.28 Million CAD | 76.117% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 91.05% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 86.89% |
| 1933 Industries Inc. | -9.34 Million CAD | 91.606% |
| Red Light Holland Corp. | -6.44 Million CAD | 87.826% |
| Xebra Brands Ltd. | -1.55 Million CAD | 49.515% |
| Adastra Holdings Ltd. | -1.79 Million CAD | 56.248% |